Literature DB >> 28729477

Blood eosinophil count and exacerbation risk in patients with COPD.

Marjan Kerkhof1, Samatha Sonnappa1, Dirkje S Postma2, Guy Brusselle3,4,5, Alvar Agustí6,7, Antonio Anzueto8,9, Rupert Jones10, Alberto Papi11, Ian Pavord12, Emilio Pizzichini13, Todor Popov14, Nicolas Roche15,16, Dermot Ryan17, Mike Thomas18,19, Claus Vogelmeier20,21, Alison Chisholm22, Daryl Freeman23, Mona Bafadhel12, Elizabeth V Hillyer1, David B Price24,22,25.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28729477     DOI： 10.1183/13993003.00761-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  22 in total

1.  Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  Jeong H Yun; Andrew Lamb; Robert Chase; Dave Singh; Margaret M Parker; Aabida Saferali; Jørgen Vestbo; Ruth Tal-Singer; Peter J Castaldi; Edwin K Silverman; Craig P Hersh
Journal:  J Allergy Clin Immunol       Date:  2018-04-28       Impact factor: 10.793

2.  COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry.

Authors:  Wilson D Pace; Elias Brandt; Victoria A Carter; Ku-Lang Chang; Chelsea L Edwards; Alexander Evans; Chester Fox; Gabriela Gaona; MeiLan K Han; Alan G Kaplan; Rachel Kent; Janwillem W H Kocks; Maja Kruszyk; Chantal E Le Lievre; Tessa Li Voti; Cathy Mahle; Barry Make; Amanda R Ratigan; Asif Shaikh; Neil Skolnik; Brooklyn Stanley; Barbara P Yawn; David B Price
Journal:  Ann Fam Med       Date:  2022 Jul-Aug       Impact factor: 5.707

3.  Long-term oxygen treatment need is less frequent in eosinophilic COPD patients.

Authors:  Nilüfer Aylin Acet-Öztürk; Asli G Dilektasli; Özge Aydın-Güçlü; Ezgi Demirdöğen; Funda Coşkun; Ahmet Ursavaş; Mehmet Karadağ; Esra Uzaslan
Journal:  Clin Respir J       Date:  2021-10-26       Impact factor: 1.761

4.  Frequency of Blood Eosinophilia in newly diagnosed Chronic Obstructive Pulmonary Disease patients.

Authors:  Ghulam Maqtada Khan; Faisal Faiyaz Zuberi; Syeda Bizat Uz Zahra; Lubna Ghafoor
Journal:  Pak J Med Sci       Date:  2020 May-Jun       Impact factor: 1.088

5.  Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

Authors:  Dave Singh; Jadwiga A Wedzicha; Salman Siddiqui; Alberto de la Hoz; Wenqiong Xue; Helgo Magnussen; Marc Miravitlles; James D Chalmers; Peter M A Calverley
Journal:  Respir Res       Date:  2020-09-17

Review 6.  Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD.

Authors:  Konstantinos Kostikas; Caterina Brindicci; Francesco Patalano
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

7.  Precision medicine in COPD: review of mepolizumab for eosinophilic COPD.

Authors:  Gabriella Long; Jasmine Wall
Journal:  Breathe (Sheff)       Date:  2018-12

8.  Blood eosinophil count-guided corticosteroid therapy and as a prognostic biomarker of exacerbations of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Tao Liu; Zi-Jian Xiang; Xiao-Meng Hou; Jing-Jing Chai; Yan-Li Yang; Xiao-Tong Zhang
Journal:  Ther Adv Chronic Dis       Date:  2021-07-07       Impact factor: 5.091

9.  Effect of the asthma-chronic obstructive pulmonary disease syndrome on the stroke, Parkinson's disease, and dementia: a national cohort study.

Authors:  Jun-Jun Yeh; Yu-Feng Wei; Cheng-Li Lin; Wu-Huei Hsu
Journal:  Oncotarget       Date:  2017-12-26

10.  Association between COPD exacerbations and lung function decline during maintenance therapy.

Authors:  Marjan Kerkhof; Jaco Voorham; Paul Dorinsky; Claudia Cabrera; Patrick Darken; Janwillem Wh Kocks; Mohsen Sadatsafavi; Don D Sin; Victoria Carter; David B Price
Journal:  Thorax       Date:  2020-06-12       Impact factor: 9.139
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.